Abbott

Offers spinal cord stimulation, dorsal root ganglion stimulation, and deep brain stimulation systems for chronic pain and movement disorders. Neuromodulation division includes Proclaim, Eterna, and Infinity platforms. Competes directly with Medtronic and Boston Scientific in the clinical neurostim market.

Major incumbent with FDA-approved neuromodulation portfolio, including proprietary waveforms and closed-loop sensing capabilities, representing established competition for BCI startups.

abbott.com Neuromodulation & Stimulation

United Statespublic · ABT

At a glance

Total raised

Undisclosed

no public funding on record

Headcount

10k+

approximate · public range

Headquarters

Chicago

United States

Founded

—

Status

Public

Ticker · ABT

Subsector

Neuromodulation & Stimulation

For subscribers

Subscribe to see the full profile

Including Funding rounds, Bull / Bear thesis, Stock + earnings, Roster changes, Patents, News, and Open roles.

Already subscribed? Sign in →

Abbott

At a glance

Subscribe to see the full profile

Funding history

Stock performance

AI bull / bear

In the news

Watch

Leadership

Products

Proclaim XR SCS System

Eterna SCS System

Liberta RC Deep Brain Stimulation System

Open roles

Compare Abbott with